RMC No. 100-2024 — Publishing the full text of the August 7, 2024 letter from the Food and Drug Administration of the Department of Health endorsing updates to the list of VAT-exempt products under Republic Act (RA) No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act) Digest | Full Text | Annex A

REPUBLIC OF THE PHILIPPINES PESN USOT

DEPARTMENT OF FINANCE BUREAU OF INTERNAL REVENUE Que zon City P O S 20Z4

Bringing in Revenues for Nation-bullding BY T ADmiN unit"- 1 TIME: &:05 pM

SEP 0 4 2024

REVENUE MEMORANDUM CIRCULAR NO. 100 -2024

SUBJECT : Publishing the Full Text of the August 7, 2024 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing Updates to the List of VAT-Exempt Products Under Republic Act (R.A.) No. 10963 (TRAIN Law) and R.A.No. 11534 (CREATE Act)

TO : All Internal Revenue Officers and Others Concerned

concerned, attached is the August 7, 2024 letter (Annex "A") from Dr. Samuel A. Zacate, For the information and guidance of all internal revenue officers, employees and others

Director General of the FDA, for the inclusion of certain medicines for cancer, diabetes, hypertension, kidney diseases, mental illness and tuberculosis to the published List of VAT- Exempt Medicines Under the TRAIN Law and the CREATE Act.

As clarified under Q&A No. 1 of RMC No. 99-2021, the effectivity of the VAT exemption of the covered medicines and medical devices under the CREATE Act shall be on the date of publication by the FDA of the updates to the said list.

wide a publicity as possible. All concerned are hereby enjoined to be guided accordingly and give this Circular as

Commissioner of Internal Revenue ROMEO D. LUMAGUI, JR.

2c

(por RSO/DPO'No.cIR Mm2.4ug 29.302 Dato of.sioning: c+ 624 Logat Group MariSSAO. CabReros Deputy Commissioner Omcor-ir-Charge